Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Topical dutasteride for male pattern baldness
RBR-8ygm86fPhase 3Completed
- Sponsor
- Clinica Sanabria
- Start
- Apr 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial of dutasteride in androgenetic alopecia (AGA) (2 arms), sponsored by Clinica Sanabria. Started Apr 2024; status: completed.
02
Drugs
dutasteride
03
Conditions
androgenetic alopecia (AGA)
Beyond the preview
Go deeper on RBR-8ygm86f.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on RBR-8ygm86f.